Paclitaxel is under clinical development by InnoUp Farma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...
AMT-676 is under clinical development by Multitude therapeutics and currently in Phase I for Neuroendocrine Tumors.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback